NCT00017394
- Conditions
- Breast Diseases, Breast Neoplasms, Breast Neoplasms, Male, +7 more
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
Clinical trial condition
Stage IV Breast Cancer
Explore clinical trials studying Stage IV Breast Cancer. Study availability and eligibility vary by location and protocol.
141 public trials
3 recruiting studies
Stage IV Breast Cancer trial results
NCT00030498
- Conditions
- Adenocarcinoma, Adenoma, Adnexal Diseases, +185 more
- Locations
-
- Cancer and Leukemia Group B Chicago, Illinois, United States
NCT00316407
- Conditions
- Adnexal Diseases, Breast Diseases, Breast Neoplasms, +23 more
- Locations
-
- University of New Mexico Cancer Center Albuquerque, New Mexico, United States
- Swedish Medical Center Cancer Institute Seattle, Washington, United States
NCT00146549
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
NCT00378313
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +9 more
- Locations
-
- NSABP Foundation, Inc. Pittsburgh, Pennsylvania, United States
Active, Not Recruiting
Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Stage IV or Unresectable, Recurrent Triple Negative Breast Cancer
NCT03971409
- Conditions
- Breast Diseases, Breast Neoplasms, Invasive Breast Carcinoma, +13 more
- Locations
-
- O'Neal Comprehensive Cancer Center Birmingham, Alabama, United States
- University of California, San Francisco San Francisco, California, United States
- Georgetown University Washington D.C., District of Columbia, United States
- University of Chicago Medicine Comprehensive Cancer Center Evergreen Park, Illinois, United States
Active, Not Recruiting
Vaccine Therapy in Treating Patients With HER2-Negative Stage III-IV Breast Cancer
NCT02157051
- Conditions
- Breast Diseases, Breast Neoplasms, HER2 Negative Breast Carcinoma, +10 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
Active, Not Recruiting
Copper Cu 64-DOTA-Trastuzumab PET in Predicting Response to Treatment With Ado-Trastuzumab Emtansine in Patients With Metastatic HER2 Positive Breast Cancer
NCT02226276
- Conditions
- Bone Metastases, Breast Diseases, Breast Neoplasms, +10 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
Active, Not Recruiting
Positron Emission Tomography in Women With Advanced HER2-Positive Breast Cancer
NCT01093612
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
- Locations
-
- City of Hope Duarte, California, United States
NCT05840211
- Conditions
- Breast Diseases, Breast Neoplasms, Locally Advanced or Unresectable Metastatic Breast Cancer, +5 more
- Locations
-
- Ironwood Physicians P.C. dba Ironwood Cancer and Research Centers Chandler, Arizona, United States
- Los Angeles Hematology Oncology Medical Group Los Angeles, California, United States
- Stanford Cancer Institute Palo Alto, California, United States
- University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States